Wolverine Trading, LLC Compugen LTD Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $60,123 - $105,252	-14,700 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $11,020 - $15,238	1,900 Added 14.84%	14,700 $87,000
Q2 2021 Aug 06, 2021	SELL	$6.87 - $9.16 $6,183 - $8,244	-900 Reduced 6.57%	12,800 $107,000
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $22,243 - $39,933	-2,900 Reduced 17.47%	13,700 $112,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $200,362 - $297,970	16,600 New	16,600 $214,000
Q4 2019 Feb 12, 2020	SELL	$3.9 - $6.16 $56,160 - $88,704	-14,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.49 $46,956 - $70,044	-15,600 Reduced 52.0%	14,400 $61,000
Q2 2019 Aug 20, 2019	BUY	$2.8 - $4.14 $17,360 - $25,667	6,200 Added 26.05%	30,000 $115,000
Q1 2019 May 15, 2019	BUY	$2.35 - $4.19 $16,685 - $29,749	7,100 Added 42.51%	23,800 $99,000
Q4 2018 Feb 14, 2019	SELL	$2.17 - $3.8 $5,642 - $9,880	-2,600 Reduced 13.47%	16,700 $39,000
Q3 2018 Nov 14, 2018	BUY	$3.0 - $4.05 $57,900 - $78,165	19,300 New	19,300 $74,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.